
LSX World Congress USA 2026
LSX World Congress USA is a senior-level life sciences partnering and investment conference held in Boston, formed by the merger of EBD Group's BioPharm America with the LSX World Congress series. It is part of Biotech Week Boston, a wider gathering of the biopharmaceutical ecosystem. The event brings together biotech founders and executives, active investors, and pharma leaders to drive funding, partnering, and company growth. The Congress is built around the conversations that matter most to companies at every stage of growth — from emerging biotechs seeking capital and visibility to later-stage companies pursuing strategic partnerships and commercial momentum. Through high-quality content, 1:1 partnering, company showcases, and investor engagement, it helps life science leaders build relationships, secure funding, and advance strategic goals. Attendees include biotech CEOs, the sector's most active investors, big pharma and commercial leaders, and a selection of trusted advisors. Whether you are an early-stage startup preparing for seed or Series A/B conversations, or an established company looking to connect with pharma for licensing and co-development, LSX World Congress USA offers a focused platform to raise your profile, meet the right people, and accelerate what comes next.
